Gavel,
> Roche deal is nothing to talk about.
Well, you're quite right the terms of the deal, like everything Roche enters into at this level, are confidential. So they can't be talked about. :)
But it likely contains substantial milestone payments if PYC hit any candidates.
> a free ride on the name.
Which is not to be sneezed at. The Roche deal may be one reason PYC is now being taken seriously by other big pharma players.
> But if one were to start accumulating now, then in the next month or two something more substantial may happen.
Agreed.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
0.030(2.21%) |
Mkt cap ! $810.7M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.39 | $1.33 | $103.4K | 75.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2600 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 14999 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |